Development of a Urine-Based Point-of-Care Test for Adherence to Antiretroviral Drugs

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a single-center, open label study to identify adherence levels of commonly prescribed FDA-approved antiretroviral agents by tracking the decline of drug concentrations in plasma, urine and saliva following abrupt drug cessation in HIV-negative adults. Results from this study may provide support for development of a point of care urine testing device to monitor drug adherence.
Epistemonikos ID: 83abd2bab40303ce21416f364e3edc236ae51a61
First added on: May 07, 2024